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Heart Failure With a
Preserved Ejection Fraction
What Is in a Name?*
Mathew S. Maurer, MD,†
Scott L. Hummel, MD, MS‡§
New York, New York; and Ann Arbor, Michigan
The terminology for what has become the most common
form of heart failure (1) has evolved in the medical litera-
ture. Two decades ago, Kitzman et al. (2) studied a small
group of patients with heart failure and normal left ventric-
ular ejection fraction and demonstrated that exercise-
induced increases in pulmonary capillary wedge pressure
were not accompanied by increases in end-diastolic volume.
As a result of this and other observations of ventricular
diastolic dysfunction (3,4), the term diastolic heart failure
became popular and remains in common use today. As the
epidemic of this condition grew (1), efforts to measure
diastolic function, to understand the mechanisms of dia-
stolic dysfunction, and to develop strategies to enhance
diastolic performance intensified. Unfortunately, although
important advances have been made, this approach has not
yet led to significantly better outcomes. Much controversy
now exists over the role of diastolic dysfunction in heart
failure with normal left ventricular ejection fraction.
See page 265
Accordingly, in this issue of the Journal, Haykowsky et al.
(5) sought to replicate their previous observation that effort
intolerance in patients with heart failure and normal ejec-
tion fraction relates to failure of the Frank-Starling mech-
anism (i.e., a blunted end-diastolic volume response to
exercise that limits exercise stroke volume and cardiac
output). They studied 48 well-characterized patients with
heart failure with preserved ejection fraction (HFPEF), and
28 sedentary but otherwise healthy age-matched controls.
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Hummel is a consultant for the Thoratec Corp.Participants exercised to exhaustion on an upright cycle
ergometer with concomitant oxygen consumption testing
and transthoracic echocardiography. Cardiac output at the
various workloads was estimated using myocardial volumes
from the 4-chamber apical view, enabling algebraic estima-
tion of the arteriovenous oxygen difference (A-VO2).
The provocative findings in this study in many ways did
not support commonly accepted assumptions about HFPEF.
Measured end-systolic and -diastolic ventricular volumes
were lower in HFPEF patients than in controls, both at rest
and at peak exercise. However, patients and controls had
similar percentage increases in end-diastolic volume, stroke
volume, and cardiac output at matched workloads, suggest-
ing that HFPEF patients did not have difficulty filling the
left ventricle during exercise. In fact, the percentage of
increase in end-diastolic volume at peak exercise was actu-
ally greater in the HFPEF patients than in the controls.
Interestingly, the 2 factors limiting cardiac output at peak
exercise in HFPEF patients were impaired ventricular
systolic and heart rate reserve. Moreover, although peak VO2
was partially determined by peak cardiac output, the change
in A-VO2 from rest to peak exercise was a stronger predictor
of peak VO2 in HFPEF patients. The authors concluded
hat exercise limitations in HFPEF patients are not primar-
ly due to diastolic dysfunction and hypothesized that
oncardiac factors are important drivers for symptoms in
FPEF.
We commend Haykowsky et al. (5) not only for their
illingness to reevaluate widely held assumptions, but also
or conducting a technically demanding study in a patient
opulation that is notoriously difficult to recruit. Their
FPEF study patients were similar to large epidemiological
ohorts, which helps reduce uncertainty about the general-
zability of their results. Despite a population likely to have
oor echocardiographic windows, they obtained adequate
mages during upright cycle ergometry to evaluate ventric-
lar volumes in 48 of 59 patients. Notably, the authors
resent important findings that are not consistent with their
nitial hypothesis.
Some additional aspects of the study population deserve
ention. Overall, the patients reported relatively mild
ymptoms and had modest evidence of neurohormonal
ctivation. In addition, subjects had relatively “pure” HFPEF,
ith no known coronary, pulmonary, or renal disease.
lthough these exclusions facilitated recruitment of a co-
ort that could perform adequate exercise and enabled
nalysis of the specific physiological factors that limit
xertional capacity, in community and hospitalized HFPEF
atients, multiple medical comorbidities are the rule, not
he exception. Conditions such as diabetes and renal insuf-
ciency impair endothelial function and could affect A-VO2;
skeletal muscle wasting (sarcopenia), often present in older
heart failure patients, could reduce peripheral oxygen ex-
traction. Many HFPEF patients are anemic, which would
exacerbate problems related to impaired peripheral oxygen
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HFPEF: What Is in a Name? July 12, 2011:275–7extraction in the setting of reduced oxygen delivery. It is not
known whether HFPEF patients with a more severe phe-
notype or those with commonly found comorbidities would
have similar physiological findings with exercise.
Exercise oxygen consumption testing is commonly used
to evaluate patients with heart failure. However, particularly
in frail older adult heart failure patients, measured peak VO2
does not always predict heart failure symptom burden (6).
As seen in Figure 1 from the Haykowsky et al. study (5), at
low matched workloads (rest to 25 W), curves for measured
cardiac output, A-VO2 diff, and VO2 are nearly identical in
FPEF patients and controls; between-group differences in
hese parameters become apparent only at peak exercise.
lder adult patients with systolic heart failure have impaired
xygen kinetics with submaximal exercise (i.e., take longer
o increase oxygen consumption at the start of exercise and
ave an oxygen “debt” to repay after activity (7). Submaxi-
al oxygen kinetics have not previously been reported in
FPEF, but could further clarify the relationships between
ardiac output, A-VO2, and the intolerance of low-workload
activities reported by many HFPEF patients.
As noted by Haykowsky et al. (5), the results of their
present study should now not be surprising. Their original
paper (2) included a small cohort (n  7) in whom several
had etiologies of heart failure (amyloid cardiomyopathy and
obstructive hypertrophic cardiomyopathy), which are now
well recognized to have limited use of the Frank-Starling
mechanism due to impaired diastolic filling during exercise
(8). These disorders are also not associated with long-
standing systemic hypertension, the most common contrib-
uting factor to HFPEF. Pulmonary capillary wedge pres-
sures were used in their original cohort as a surrogate of the
left ventricular end-diastolic pressure. At high exercise heart
rates, these pressures can dissociate, making the true con-
tribution of ventricular diastolic function difficult to deter-
mine (9). As summarized in their Table 5 (5), several other
contemporary studies also show that impaired ventricular
diastolic filling does not limit exercise tolerance in the
majority of HFPEF patients.
The 1995 ACC/AHA guidelines referred to heart failure
with normal left ventricular ejection fraction as “heart failure
due to diastolic dysfunction” (10). The realization that not
all patients had diastolic dysfunction (11) and the hetero-
geneity of the population with this syndrome (12,13)
contributed to a change in nomenclature. In 2001, guide-
lines used the term “heart failure with preserved systolic
function” (14), until subsequent studies (including the
present investigation [5]) documented impaired ventricular
systolic reserve in these individuals. The data presented by
Haykowsky et al. (5) and others raise the intriguing possi-
bility that vascular, skeletal muscular, and/or other periph-
eral factors contribute to HFPEF, and such areas are ripe
for further investigation.
Regardless of the physiological mechanisms that are most
significant in an individual patient, HFPEF probably takes
decades to develop. Particularly in older patients withmultiple comorbidities, HFPEF may be difficult to reverse.
Strategies aimed at HFPEF prevention and improving
quality of life in patients with prevalent disease are sorely
needed (1,15). In recent years, the scope of HFPEF research
has broadened in an attempt to define the common under-
lying mechanisms that mediate the diverse cardiac and
vascular abnormalities of this syndrome. One emerging risk
factor consistently associated with cardiovascular remodel-
ing and dysfunction in HFPEF animal models (16,17) and
recently confirmed in human HFPEF (18) is chronic
inflammation, which independently predicts incident HFPEF
in community-dwelling older adults (19).
Viewed in this context, studying the response to acute
and chronic exercise in HFPEF can provide much more
than hemodynamic information. Kitzman et al. (20) previ-
ously showed that exercise training improves peak VO2,
submaximal exercise tolerance, and quality of life in HFPEF.
Exercise training reduces chronic inflammation in some pop-
ulations, including obese, insulin-resistant hypertensives (21)
nd frail, obese older adults (22) who may be at risk of
eveloping HFPEF. The effects of dietary patterns, the key
nstigator of inflammation and adverse cardiovascular remod-
ling in HFPEF animal models (16,17), have not been
xtensively investigated in prevalent HFPEF (23) but appear
imilar in potential HFPEF precursors (24,25). Given the
argely disappointing results of clinical drug trials to date in
FPEF, further lifestyle modification studies could produce
aluable adjuncts to therapy, provide a window into patho-
hysiology, and eventually lead to preventive strategies for this
ajor public health threat.
The most recent heart failure guideline updates (26,27)
se the descriptive term HFPEF. This evolution in nomen-
lature is appropriate for several reasons. First, the term
iastolic heart failure suggests a single operative mechanism,
hich is not present in every patient with HFPEF and, to
ate, has not been targetable by any specific intervention.
econd, the change in nomenclature keeps pace with the
ecent scientific discovery. Because the HFPEF terminology
s observational of the phenotype without suggesting a
redominant mechanism, it paves the way for new studies
hat will perhaps lead to innovative ways to understand and
reat the condition. As our scientific knowledge evolves, we
ill develop newer methods to classify subjects with HFPEF
nd likely different names, ideally based on treatable patho-
hysiological mechanisms. The past 20 years suggest that
eeping an open mind about the nomenclature of HFPEF
ontributes to a broader, more inclusive, and, we hope and
xpect, a more productive view of this complex and heter-
geneous syndrome.
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